FORESITE CAPITAL MANAGEMENT VI LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ALMS | 4.25M | $16.95M |
 | VSTM | 2.62M | $23.09M |
 | CGON | 2.22M | $89.48M |
 | CRVS | 1.73M | $12.76M |
 | RAPT | 1.56M | $40.30M |
 | CNTA | 1.31M | $31.86M |
 | DNLI | 1.00M | $14.52M |
 | CASI | 980K | $1.63M |
 | AKRO | 245K | $11.63M |
 | KYMR | 146K | $8.28M |
 | HNGE | 135K | $6.63M |
 | RNA | 40K | $1.74M |
Alumis Inc. Common Stock
ALMS
Shares Held
4.25M
Value
$16.95M
Verastem, Inc.
VSTM
Shares Held
2.62M
Value
$23.09M
CG Oncology, Inc. Common stock
CGON
Shares Held
2.22M
Value
$89.48M
Corvus Pharmaceuticals, Inc.
CRVS
Shares Held
1.73M
Value
$12.76M
RAPT Therapeutics, Inc.
RAPT
Shares Held
1.56M
Value
$40.30M
Centessa Pharmaceuticals plc
CNTA
Shares Held
1.31M
Value
$31.86M
Denali Therapeutics Inc.
DNLI
Shares Held
1.00M
Value
$14.52M
CASI Pharmaceuticals, Inc.
CASI
Shares Held
980K
Value
$1.63M
Akero Therapeutics, Inc.
AKRO
Shares Held
245K
Value
$11.63M
Kymera Therapeutics, Inc.
KYMR
Shares Held
146K
Value
$8.28M
Hinge Health, Inc.
HNGE
Shares Held
135K
Value
$6.63M
Avidity Biosciences, Inc.
RNA
Shares Held
40K
Value
$1.74M